scispace - formally typeset
Journal ArticleDOI

Tocilizumab for severe refractory neuro-Behçet: Three cases IL-6 blockade in neuro-Behçet

TLDR
The data suggest that TCZ may be considered for patients with refractory NBD, and the prednisone dose could successfully be tapered to about 20mg/day, while in another patient glucocorticoids could safely be withdrawn.
About
This article is published in Seminars in Arthritis and Rheumatism.The article was published on 2015-02-01. It has received 70 citations till now.

read more

Citations
More filters
Journal ArticleDOI

The Two-Faced Cytokine IL-6 in Host Defense and Diseases

TL;DR: The defensive functions of IL-6 and various pathological conditions are compared and the important role ofIL-6 in host defense should always be kept in mind in clinical practice.
Journal ArticleDOI

Pathogenesis of Behçet’s disease: autoinflammatory features and beyond

TL;DR: Understanding of major histocompatibility complex (MHC) Class I-driven inflammatory response is expected to provide insights for the development of better treatment and remission-induction options in Behçet's disease as well as in ankylosing spondylitis (AS) and psoriasis.
Journal ArticleDOI

Behçet’s disease in children, an overview

TL;DR: BD is a systemic inflammatory disease with a variable vasculitis that carries a strong genetic component and young males have the worst prognosis with significantly more frequent neurological, ocular and vascular involvement.
References
More filters
Journal ArticleDOI

The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria

TL;DR: Behçet's disease (BD) is a chronic, relapsing, inflammatory vascular disease with no pathognomonic test.
Journal ArticleDOI

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

TL;DR: Parenchymal involvement, elevated protein and/or pleocytosis in the CSF, 'brainstem +' type involvement, primary or secondary progressive course and relapse during steroid tapering were all associated with a poorer prognosis.
Journal ArticleDOI

Physiological and pathological roles of interleukin-6 in the central nervous system.

TL;DR: It appears that IL-6 may play a role in both physiological and pathophysiological processes in the CNS, similar to that commonly observed in various neurological diseases.
Journal ArticleDOI

Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain

TL;DR: A critical role for a proinflammatory cytokine is suggested in the cognitive deficits and associated neuroinflammatory changes that have been documented in neurodegenerative diseases such as Alzheimer disease and AIDS.
Journal ArticleDOI

IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.

TL;DR: Findings indicate that anti-IL-6R mAb treatment might represent a novel therapy for human MS through the inhibition of the development of MOG-peptide-specific Th17 cells and Th1 cells, which in turn leads to reduced infiltration of T cells into the CNS.
Related Papers (5)